Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial

Authors :: Marie Overgaard
Hanne Melgaard Nielsen
Trine Tramm
Inger Højris
Trine Lønbo Grantzau
Jan Alsner
Birgitte Vrou Offersen
Jens Overgaard
Source :: Overgaard, M, Nielsen, H M, Tramm, T, Højris, I, Grantzau, T L, Alsner, J, Offersen, B V, Overgaard, J & DBCG Radiotherapy Group 2022, ' Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial ', Radiotherapy and Oncology, vol. 170, pp. 4-13 . https://doi.org/10.1016/j.radonc.2022.03.008
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.
Abstract: Background: Between 1982 and 1990 the Danish Breast Cancer Cooperative Group (DBCG) conducted a randomized trial in high-risk pre- and postmenopausal (

Subjects :: Ischemic heart disease
Denmark
Breast Neoplasms
Hematology
Postmastectomy radiotherapy
Patterns of failure
Adjuvant therapy
Tamoxifen
Loco-regional recurrence
Oncology
CMF
Humans
Female
Radiotherapy, Adjuvant
Radiology, Nuclear Medicine and imaging
Neoplasm Recurrence, Local
High-risk early breast cancer
Mastectomy

Full Text Access

Tools